A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection

NCT04637828 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
178
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Genoscience Pharma